These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 15636158

  • 1. [Polybacterial immunostimulators in medical practice].
    Petrunov BP.
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (6):122-6. PubMed ID: 15636158
    [Abstract] [Full Text] [Related]

  • 2. Cellular and humoral systemic and mucosal immune responses stimulated by an oral polybacterial immunomodulator in patients with chronic urinary tract infections.
    Marinova S, Nenkov P, Markova R, Nikolaeva S, Kostadinova R, Mitov I, Vretenarska M.
    Int J Immunopathol Pharmacol; 2005; 18(3):457-473. PubMed ID: 16164822
    [Abstract] [Full Text] [Related]

  • 3. [The action on the immune system of respivax--a polybacterial vaccine for the peroral immunotherapy and immunoprophylaxis of nonspecific respiratory tract infections].
    Petrunov B, Nenkov P, Tsvetanov I, Dragulev B.
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Apr; (4):34-9. PubMed ID: 1882604
    [No Abstract] [Full Text] [Related]

  • 4. Experimental investigations on the immunomodulating activity of polybacterial preparation for peroral immunotherapy and immunoprophylaxis of uroinfections.
    Nenkov P, Mitov I, Marinova S, Markova R.
    Int J Immunopharmacol; 1995 Jun; 17(6):489-96. PubMed ID: 7499025
    [Abstract] [Full Text] [Related]

  • 5. Overview on the clinical studies with Urostim immunostimulator against urogenital infections.
    Nenkov P.
    Adv Exp Med Biol; 2000 Jun; 485():325-9. PubMed ID: 11109124
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of a new immunostimulating bacterial lysate in the prophylaxis of acute lower respiratory tract infections. A randomised, open, controlled clinical trial.
    Rossi S, Tazza R.
    Arzneimittelforschung; 2004 Jun; 54(1):50-6. PubMed ID: 14979609
    [No Abstract] [Full Text] [Related]

  • 7. Prevention of recurrent upper respiratory tract infections in a community of cloistered nuns using a new immunostimulating bacterial lysate. A randomized, double-blind clinical trial.
    Tricarico D, Varricchio A, D'Ambrosio S, Ascione E, Motta G.
    Arzneimittelforschung; 2004 Jun; 54(1):57-63. PubMed ID: 14979610
    [Abstract] [Full Text] [Related]

  • 8. Reduction of the number and severity of respiratory tract infections in children by oral immunostimulation.
    Riedl-Seifert RJ, van Aubel A, Kämmereit A, Elsasser U.
    Adv Exp Med Biol; 1995 Jun; 371B():799-802. PubMed ID: 7502900
    [No Abstract] [Full Text] [Related]

  • 9. [Mucosal immunity with implications for use in developing a new generation of vaccines].
    Osek J, Truszczyński M.
    Postepy Hig Med Dosw; 1995 Jun; 49(4):469-86. PubMed ID: 8657643
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Immune preparation IRS-19 in the treatment of inflammation in the upper respiratory tracts].
    Gunchikov MV, Vinnikov AK.
    Vestn Otorinolaringol; 2001 Jun; (1):40. PubMed ID: 11247247
    [No Abstract] [Full Text] [Related]

  • 13. Immunostimulating and protective effects of an oral polybacterial immunomodulator 'Dentavax' in a rabbit experimental model.
    Marinova S, Tchorbadjiiska L, Petrunov B, Cvetanov J, Nenkov P, Konstantinova D, Markova R.
    Int J Immunopharmacol; 2000 Nov; 22(11):843-54. PubMed ID: 11090693
    [Abstract] [Full Text] [Related]

  • 14. [The results of a clinico-immunological examination of patients with infectious-allergic bronchial asthma undergoing treatment with the polybacterial immunostimulant Respivax].
    Petrovska Ia, Tsvetkova L, Petrova O.
    Ter Arkh; 1990 Nov; 62(3):72-5. PubMed ID: 2368002
    [Abstract] [Full Text] [Related]

  • 15. [Prevention of recurrent infection of the upper and lower airways. Multicenter, open study over three months].
    Debelic M, Eckenberger HP.
    Fortschr Med; 1992 Nov 30; 110(30):565-70. PubMed ID: 1468743
    [Abstract] [Full Text] [Related]

  • 16. Open comparative, randomized controlled clinical study of a new immunostimulating bacterial lysate in the prophylaxis of upper respiratory tract infections.
    Macchi A, Vecchia LD.
    Arzneimittelforschung; 2005 Nov 30; 55(5):276-81. PubMed ID: 15960427
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Trained Immunity-Based Vaccine in B Cell Hematological Malignancies With Recurrent Infections: A New Therapeutic Approach.
    Ochoa-Grullón J, Benavente Cuesta C, González Fernández A, Cordero Torres G, Pérez López C, Peña Cortijo A, Conejero Hall L, Mateo Morales M, Rodríguez de la Peña A, Díez-Rivero CM, Rodríguez de Frías E, Guevara-Hoyer K, Fernández-Arquero M, Sánchez-Ramón S.
    Front Immunol; 2020 Nov 30; 11():611566. PubMed ID: 33679698
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of spontaneous pulmonary metastases of Lewis lung carcinoma by oral treatment with Respivax and Broncho-Vaxom.
    Kassabov KT, Stoychkov JN.
    Cancer Immunol Immunother; 1991 Nov 30; 33(5):307-13. PubMed ID: 1868489
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.